v3.26.1
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of Segment Expenses

 

(In thousands)   2025     2024  
   

For the Years Ended

December 31,

 
(In thousands)   2025     2024  
Research and Development:                
Employee expense   $ 5,339     $ 4,984  
Clinical     3,216       5,345  
Product     840       1,147  
Other     586       773  
Total research and development     9,981       12,249  
Selling, general and administrative expense                
Employee expense     6,147       6,285  
Professional fees     1,558       2,451  
Occupancy     597       626  
Insurance     610       655  
Other     2,006       1,560  
Total selling, general and administrative expense     10,918       11,577  
Loss from operations     20,899       23,826  
Adjustments and reconciling items     (1,427 )     (2,007 )
Net loss   $ 19,472     $ 21,819